News

Regeneron Pharmaceuticals (NasdaqGS:REGN) announced a major expansion of its manufacturing capacity, including a $3 billion deal with Fujifilm Diosynth Biotechnologies and further investments at its ...
As pharma giants line up one after another to tout their investment plans in the U.S., Regeneron is adopting a different tack ...
With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics ...
Swiss drugmaker Roche will spend $50B to expand its U.S. manufacturing, while New York-based Regeneron will spend more than ...
TOKYO -- Fujifilm Holdings announced on Tuesday that it has signed a contract worth more than $3 billion to manufacture ...